Ondansetron: reasons to be restrictive
- 1 May 1996
- journal article
- letter
- Published by Elsevier in The Lancet
- Vol. 347 (9013) , 1484-1485
- https://doi.org/10.1016/s0140-6736(96)91720-1
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Hypersensitivity reactions associated with 5-hydroxytryptamine3-receptor antagonists: a class effect?The Lancet, 1996
- Anaphylactoid-Anaphylactic Reactions Associated with OndansetronAnnals of Internal Medicine, 1993
- Ondansetron and chest painThe Lancet, 1992
- Validity of skin tests to cyclophosphamide and metabolitesJournal of Allergy and Clinical Immunology, 1991
- GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesis.Journal of Clinical Oncology, 1989